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Highlights 
 SPiQE combines serial high-density surface EMG with an innovative signal-processing 
methodology  
 SPiQE identifies fasciculations in ALS patients with high sensitivity and specificity 
 The optimal noise-responsive model achieves an average classification accuracy of 88% 
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OBJECTIVES: Fasciculations are a clinical hallmark of amyotrophic lateral sclerosis (ALS). Compared 
to concentric needle EMG, high-density surface EMG (HDSEMG) is non-invasive and records 
fasciculation potentials (FPs) from greater muscle volumes over longer durations. To detect and 
characterise FPs from vast data sets generated by serial HDSEMG, we developed an automated 
analytical tool. 
 
METHODS: Six ALS patients and two control patients (one with benign fasciculation syndrome and 
one with multifocal motor neuropathy) underwent 30-minute HDSEMG from biceps and gastrocnemius 
monthly. In MATLAB we developed a novel, innovative method to identify FPs amidst fluctuating noise 
levels. One hundred repeats of 5-fold cross validation estimated the model’s predictive ability.  
 
RESULTS: By applying this method, we identified 5,318 FPs from 80 minutes of recordings with a 
sensitivity of 83.6% (+/- 0.2 SEM), specificity of 91.6% (+/- 0.1 SEM) and classification accuracy of 
87.9% (+/- 0.1 SEM). An amplitude exclusion threshold (100μV) removed excessively noisy data 
without compromising sensitivity. The resulting automated FP counts were not significantly different to 
the manual counts (p=0.394).  
 
CONCLUSION: We have devised and internally validated an automated method to accurately identify 
FPs from HDSEMG, a technique we have named Surface Potential Quantification Engine (SPiQE).  
 
SIGNIFICANCE: Longitudinal quantification of fasciculations in ALS could provide unique insight into 
motor neuron health. 
 
 
 
 
Keywords: Amyotrophic lateral sclerosis; fasciculation; high-density surface EMG; biomarker. 
 
 
Abbreviations 
ALS, amyotrophic lateral sclerosis; ATexc, amplitude exclusion threshold; ATinc, amplitude inclusion 
threshold; AUC, area under the curve; BFS, benign fasciculation syndrome; FP, fasciculation potential; 
(HD)SEMG, (High-density) surface electromyography; IFI, inter-FP interval; MMN, multifocal motor 
neuropathy; MU, motor unit; NEMG, needle electromyography; ROC, receiver operating characteristic; 
SEM, standard error of the mean; SPiQE, Surface Potential Quantification Engine. 
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1  Introduction 
ALS is caused by the progressive dysfunction and death of motor neurons and affects ~1,200 people in 
the UK every year.(Al-Chalabi and Hardiman, 2013) It typically causes progressive paralysis and death 
within three to five years of symptom onset. There is only one licensed drug in Europe (riluzole) with 
modest survival benefit.(Bensimon et al., 1994) Drug trials in ALS are time-consuming for patients, 
expensive for funders and hampered by insensitive measurements of disease progression. 
Consequently, there is a drive to discover novel biomarkers that could be incorporated into clinical trials 
to expedite drug discovery.(Benatar et al., 2016) 
 
A motor unit (MU) comprises the motor neuron cell body, axon, terminal branches and connecting 
muscle fibres. Ailing motor neurons are electrically unstable and spontaneously discharge electrical 
impulses causing fasciculation potentials (FPs).(de Carvalho and Swash, 2016b) Subsequently, the 
motor neuron becomes electrically unresponsive and dies, disrupting MU architecture through 
denervation. Orphaned muscle fibres can become re-innervated by sprouting motor axons. This 
process of denervation and reinnervation results in MU potentials becoming longer in duration with 
more complex morphologies over time.(Conradi et al., 1982, de Carvalho and Swash, 2013)  
 
These neurophysiological changes can be observed as a brief snapshot by concentric NEMG, which  
involves the insertion of a fine needle into muscles to record FPs.(Mills, 2010) This detects electrical 
activity within a small field comprising approximately 200 muscle fibres and can be painful, making 
repeated or extended recordings undesirable. Furthermore, there is little chance of recording from the 
same MU serially. An alternative approach is to use HDSEMG, where a grid of non-invasive sensors is 
applied to the skin.(Mateen et al., 2008, Howard and Murray, 1992) FPs can be recorded for longer, 
covering a greater volume of muscle, and can be repeated at regular intervals.(de Carvalho and 
Swash, 2016a)  
 
One of the biggest challenges facing surface EMG analysis is noise.(De Luca et al., 2010) This arises 
from both biological and technical factors, including the effects of soft tissue, poor skin-electrode 
contact and contamination from external electrical sources. This is likely to vary considerably between 
patients, anatomical sites and recording visits. Previous authors have used a constant threshold for FP 
detection ranging from 50-100μV.(de Carvalho and Swash, 2013, de Carvalho and Swash, 2016a) We 
set out to explore the optimal analytical pipeline to account for varying noise levels.  
 
The unique properties of serial HDSEMG predict an ability to characterise the number, temporal 
patterns and morphology of FPs over time. In order to capitalise on this, it was necessary to devise an 
automated system capable of processing large data sets in a systematic and robust way. This system, 
which we have named Surface Potential Quantification Engine (SPiQE), is accurately able to identify 
FPs from raw HDSEMG recordings as a measure of motor neuron health and may act as a biomarker 
of disease progression. 
 
2  Methodology 
2.1  Patient characteristics 
Six patients with ALS and two control patients (one with benign fasciculation syndrome and one with 
multifocal motor neuropathy) underwent 42 assessments in total at intervals of at least one month 
(table 1). ALS patients were diagnosed with probable or definite ALS using the revised El Escorial 
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Criteria.(Brooks et al., 2000) Ethical approval was obtained from the North of Scotland Research Ethics 
Service (Ref: 15/NS/0103). Patients were recruited from the King’s College Hospital Motor Nerve Clinic 
between Jan-Feb 2016.    
 
Patient  
No. 
Age  
(years) 
Gender Diagnosis 
Site of 
symptom  
onset 
Duration 
since  
symptom  
onset 
(months) 
Biceps power 
(MRC scale, 
5=normal) 
Gastrocnemius 
power  
(MRC 
scale, 
5=norm
al) 
Number of  
assessments  
undertaken 
R L R L 
1 59 M ALS Left leg 24 5 5 5 5 4 
2 57 M ALS Right arm 19 4 4 4 4 5 
3 50 M ALS Left arm 23 2 2 5 5 4 
4 58 M ALS Right arm 60 1 1 5 5 6 
5 59 F ALS Bulbar 27 5 5 5 5 6 
6 61 M ALS Left arm 10 5 5 5 5 7 
7 68 F MMN Left arm 204 4 5 5 5 6 
8 57 M BFS Both legs 8 5 5 5 5 4 
 
Table 1. Patient characteristics. ALS, amyotrophic lateral sclerosis; MMN, multifocal motor neuropathy; BFS, benign 
fasciculation syndrome. Muscle powers were assessed at baseline by the same clinician (JB). 
 
2.2  Data collection 
At each assessment, 30-minute HDSEMG recordings were taken from biceps brachii and medial 
gastrocnemii bilaterally (left-sided muscles were recorded simultaneously followed by right-sided 
muscles). The sensor had 64 circular electrodes (8x8 grid; electrode diameter 4.5mm; inter-electrode 
distance 8.5mm; TMS International BV, The Netherlands). Linear measurements between the medial 
inferior corner of the grid and the medial epicondyle (biceps) or malleolus (gastrocnemius) guided 
sensor placement on subsequent visits. The skin was lightly scrubbed with an abrasive gel and a 70% 
alcohol wipe. A template facilitated the application of conducting gel. Reference electrodes (3x5cm) 
were placed over the ipsilateral olecranon (biceps) and dorsum of the foot (gastrocnemius). Patients 
relaxed on the examination couch with legs in a horizontal, partially flexed position and forearms prone 
with an elbow angle of 90-120 degrees.  
 
The signals were amplified by the Refa-64 EMG Recording System (TMS International BV, The 
Netherlands). The difference between the average signal from all 64 channels and the reference 
electrode was subtracted from each channel. The raw HDSEMG data was stored as a proprietary 
Polybench file at a sampling rate of 2048Hz per channel. A 30-minute recording used approximately 
1.1GB of computer storage space. Sensors were cleaned using propran-2-ol solution in the laboratory 
and re-used up to three times according to manufacturer guidance.   
 
2.3  Computation and statistical analysis 
All FP computation was performed in MATLAB (R2014a) using specifically designed scripts. Statistical 
tests were performed in Prism V7.0a. The Mann-Whitney and Wilcoxon signed-rank tests were used for 
non-parametric data. Laptops with Intel i7 (2.5GHz) processor were used for all analysis. 
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2.4  Data processing 
Each 30-minute recording comprised 64 channels. The amplitude was recorded at intervals of ~0.5ms. 
A bandpass filter (20-500Hz) was applied without notch filtering. The perimeter channels were 
excluded as these had the poorest skin contact. Amongst the remaining 36 channels, poorly behaving 
channels were excluded in an automated way. This comprised channels that were null due to absent 
electrical contact or those that contained excessive noise, artefacts or baseline drift. A detailed 
description of these methods is beyond the scope of this manuscript, but they involved performing the 
fast fourier transform, analysing the area under the curve and calculating the amplitude range across 
the channel. Channels that fell outside the 95% confidence interval for any of these parameters were 
excluded. 
 
We have developed a novel spike detection mechanism based on a probabilistic analysis of spikes in 
relation to baseline noise. Briefly, spikes were detected based on a probability threshold of >98% 
(figure 1a). A single super-channel was created by merging spikes from different channels based on 
the maximum amplitude for each spike (figure 1b). Spatial information was retained by recording the 
channel of origin for each spike. A quality assurance process ensured each recorded spike represented 
a single spike. A train of at least four FPs with inter-FP intervals (IFIs) <250ms was designated as 
voluntary activity.  
 
2.5  Optimisation and validation of the analytical pipeline  
The aim of the automated pipeline was to identify which spikes were true FPs. The main challenge in 
this setting concerned fluctuating noise levels during and between recordings. If not appropriately 
managed, this could introduce significant inaccuracies in FP counts. Noisy data could introduce errors 
in two main ways. First, if the amplitude threshold for FP inclusion was set too low relative to the noise 
level, erroneous FPs would be counted, significantly reducing the pipeline’s specificity. Second, if there 
were sustained periods of excessively noisy and poorly interpretable data that were not excluded, then 
the time denominator would be inappropriately high, thereby underestimating FP frequencies.  
 
For these reasons, two amplitude thresholds were necessary for FPs. The first, coined the amplitude 
inclusion threshold (ATinc), signified the amplitude above which FPs would be included (phases 1-3). 
The second, coined the amplitude exclusion threshold (ATexc), acted as a trigger for exclusion of 
excessively noisy data from the analysis (phase 4).  
 
2.5.1 Phase one - Relationships between manual FP counts, noise levels and optimal amplitude 
inclusion thresholds  
Visits 1-4 were used for validation to ensure equal contributions from each patient. For each of the 32 
assessments, five one-minute sample recordings starting at 5/10/15/20/25 minutes underwent manual 
FP counts. The raw data were viewed in consecutive ten-second windows. All manual counts were 
performed by one assessor (JB) before automated processing. Pre-defined rules for FP inclusion were 
used:    
a. The autoscale function in Polybench optimised FP visualization; 
b. An FP was defined as a spike in ≥10 channels (/64) simultaneously; 
c. An FP was excluded if part of a train of similar spikes representing voluntary activity. 
 
Automated analysis was performed on the same one-minute recordings. The ATinc was varied to find 
the lowest value that produced an automated FP count equal to the manual count (+/- 1), which was 
labeled the optimal ATinc.  
 
  
 6 
Average noise bands were calculated for each detected spike (figure 2a). This was defined as the 
difference between the mean positive amplitude and the mean negative amplitude for one second 
either side of the spike. Mean noise bands were calculated for each of the one-minute recordings and 
plotted against the corresponding optimal ATinc. A best-fit line was calculated by the weighted least 
squares regression method due to heteroscedasticity of the data (figure 2b).   
 
2.5.2  Phase two – Use of one-second time windows to refine manual FP counts 
By manual inspection, each one-minute recording was categorised as either ‘relaxed’, ‘partially 
relaxed’, ‘voluntary activity’ or ‘excluded due to poor data quality’. Eighty representative ‘relaxed’ 
recordings were selected. These underwent a more precise manual FP count using one-second 
windows. In addition, the time of each FP peak (to the nearest 0.1ms) was recorded. All selected 
recordings had at least one FP detected manually.  
 
2.5.3  Phase three - Sensitivity, specificity and area under the curve (AUC) of two analytical models  
Using the same 80 one-minute recordings from phase two, two analytical models were assessed:  
 Model 1: this ignored variable noise levels and had a consistent optimal ATinc (Y=A1).  
 Model 2: this used a simple linear model (Y=A2X) to describe the relationship between mean 
noise band and optimal ATinc (see section 3.2 for justification).  
 
For each model, the threshold values A1 and A2 were varied to calculate sensitivities and specificities 
for each recording. For each threshold, the manual times of each FP peak were compared with the 
onsets and offsets of all detected FPs and excluded spikes. Automated FPs with a corresponding 
manual FP were labeled as ‘true positives’. Automated FPs without a corresponding manual FP were 
labeled as ‘false positives’. Manual FPs without a corresponding automated FP were labeled as ‘false 
negatives’. Excluded spikes without a corresponding manual FP were labeled as ‘true negatives’. For 
this validation, other exclusion criteria based on ATexc and IFI were disabled. 
 
A receiver operating characteristic (ROC) curve was produced using the median values of sensitivity 
and specificity (figure 3).(Linden, 2006) An area under the curve (AUC) was calculated for both models 
as a measure of accuracy. The optimal values for A1 and A2 were defined as the data-points closest to 
[0,1]. One hundred repeats of 5-fold cross-validation was performed on pooled data to calculate less 
biased estimates of the optimal A2 value, sensitivity, specificity and classification accuracy.(Kim, 2009, 
Kohavi, 1995)  
 
2.5.4 Phase four – Amplitude exclusion threshold (ATexc) 
Each recording from phase three was split into blocks of five seconds duration. A block was excluded if 
either: a) ATinc exceeded the ATexc for more than half of spikes; or, b) at least one ATinc was greater 
than double the ATexc. If a block were excluded, five seconds were taken from the total time and the 
FPs detected within it were excluded.  
 
In order to determine the most appropriate ATexc, the sensitivity and specificity of 80 recordings were 
calculated using a range of ATexc (20-100). The lowest ATexc that did not significantly compromise 
sensitivity was deemed optimal.    
 
2.5.5 Phase five – Comparison of manual and automated FP counts 
The optimal model was integrated into the pipeline and used to compare the automated and manual FP 
counts. A Wilcoxon signed-ranked test was used to detect any significant difference.  
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3  Results 
3.1  Data processing 
The mean number of channels included for further analysis was 19.6 +/- 0.4 SEM per recording. The 
median noise band for all patients was 4.7μV (IQR: 3.2-8.1) for biceps and 2.6μV (IQR: 1.8-4) for 
gastrocnemius (Mann-Whitney test, p<0.0001; figure 2). The one-off pre-processing stage took 10-25 
minutes per 30-minute recording. The main analysis took 1-5 minutes per recording for the first run and 
<20 seconds for subsequent runs. 
 
3.2  Optimisation and validation of the analytical pipeline  
3.2.1  Phase one - Relationships between manual FP counts, noise levels and optimal amplitude 
inclusion thresholds  
For biceps, a total of 304 one-minute recordings were analysed. Sixteen recordings were excluded due 
to poor quality. The mean noise bands and corresponding optimal ATinc were plotted (figure 2b). Nine 
outliers were excluded. The best-fit line had slope 11.0 (95% CI 10.1-11.9) and Y-intercept 0.419 (95% 
CI: -3.01-3.84), forming the equation Y=11.0X.  
 
For gastrocnemius, a total of 312 one-minute recordings were analysed. Eight recordings were 
excluded due to poor quality. The mean noise bands and corresponding optimal ATinc were plotted 
(figure 2b). Eight outliers were excluded. The best-fit line had slope 17.2 (95% CI 14.9-19.6) and Y-
intercept 0.203 (95% CI -5.35-5.75), forming the equation Y=17.2X. 
 
A general relationship of Y=AX existed between mean noise band (X) and optimal ATinc (Y), where A 
was positive. Although the use of ten-second time windows allowed a large number of recordings to be 
analysed, we proceeded to phase two, which involved fewer recordings (80) but more precise manual 
counts over one-second windows.  
 
3.2.2 Phase two – Use of one-second time windows to refine manual FP counts 
Out of 320 one-minute biceps recordings inspected manually, 170 (53.1%) were fully relaxed, 42 
(13.1%) were partially relaxed, 88 (27.5%) contained only voluntary activity and 20 (6.3%) were of too 
poor quality to judge. Out of 320 one-minute gastrocnemius recordings inspected manually, 243 
(75.9%) were fully relaxed, 46 (14.4%) were partially relaxed, 14 (4.4%) contained only voluntary 
activity and 17 (5.3%) were of too poor quality to judge. 
 
Eighty representative relaxed recordings were selected, containing 5,318 FPs in total. When counted 
manually, the median FP frequencies for 40 biceps recordings were 56.5/min (95% CI: 23-84/min) 
using one-second time windows and 25.5/min (95% CI: 7-47/min) using ten-second time windows. The 
median FP frequencies for 40 gastrocnemius recordings were 50/min (95% CI: 31-83/min) using one-
second time windows and 24.5/min (95% CI: 13-34/min) using ten-second time windows. The 
differences for each muscle were highly significant (Wilcoxon signed-rank test, p<0.0001).   
 
It was concluded that the time window used to count FPs significantly influenced the manual FP count, 
which in turn would affect the optimal ATinc. Therefore, the specific relationships from phase one were 
deemed unreliable. Instead, we explored the general relationship (Y=AX) in more detail. We set out to 
determine the optimal value for A by undertaking ROC analysis.  
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3.2.3  Phase three - Sensitivity, specificity and AUC of the analytical models 
Model 1 ignored variations in noise and took the general form Y=A1, where Y was the optimal ATinc (μV) 
and A1 was a positive value. The values of A1 that produced the optimal combined sensitivity, specificity 
and AUC were 30 for biceps and 20 for gastrocnemius (table 2). Model 2 accounted for variations in 
noise and took the general form Y=A2X, where Y was the optimal ATinc (μV), X was the mean noise 
band (μV) and A2 was a positive value. The optimal values of A2 were 8 for biceps and 7 for 
gastrocnemius (table 2).   
 
Model Muscle 
Optimal  
A1/2 
Median  
sensitivity 
(%) 
Median  
specificity 
(%) 
AUC (%) 
1 
Biceps 30 79.8 90.2 84.1 
Gastrocnemius 20 82.0 89.1 84.8 
2 
Biceps 8 85.4 91.1 88.1 
Gastrocnemius 7 84.3 88.8 88.4 
 
Table 2. Performance of two analytical models at FP identification. Model 1: Y=A1; Model 2: Y=A2X, where Y = optimal 
ATinc (μV), X = mean noise band (μV) and A2 = positive value. AUC, area under the curve. 
 
The performance of model 2 (figure 3a) was not significantly different between biceps and 
gastrocnemius at all thresholds (Mann-Whitney test: all p-values >0.05). This was not the case for 
model 1, where 8/10 specificities differed between biceps and gastrocnemius (Mann-Whitney test: p-
values<0.05).  Considering the significant difference in noise levels between the two muscles (Mann-
Whitney test: Δ=2.1μV, n=40, p=0.0029), this demonstrated the superior robustness of model 2 when 
faced with variations in noise levels. This allowed us to pool the data for model 2 (figure 3b), on which 
we performed 100 repeats of 5-fold cross validation. For 49.4% of test folds, the optimal A2 value was 
8, producing a mean classification accuracy of 87.9% (+/- 0.1 SEM), sensitivity of 83.6% (+/- 0.2 SEM) 
and specificity of 91.5% (+/- 0.1 SEM). For 50.6% of test folds, the optimal A2 value was 7, producing a 
mean classification accuracy of 85.2% (+/- 0.2 SEM), sensitivity of 86.7% (+/- 0.2 SEM) and specificity 
of 85.0% (+/- 0.3 SEM). Therefore, due to its superior accuracy, Y=8X was considered the optimal 
predictive model.  
 
3.2.4 Phase four - Amplitude exclusion threshold (ATexc) 
Lowering the ATexc beyond 100μV reduced the sensitivity and increased the specificity of the 
automated model (figure 4a). Even when the ATexc was disabled (‘off’), no further increase in sensitivity 
could be achieved. Therefore, this was a valuable way of excluding excessively noisy portions of data 
without compromising on the model’s sensitivity.   
 
3.2.5 Phase five – Performance of the optimal model  
The optimal automated method was model 2 (Y=A2X), where A2 = 8 and ATexc = 100 (figure 5). For 80 
recordings with high precision FP counts, there was no significant difference between the manual and 
automated counts (Wilcoxon signed-rank test, p=0.394).  
 
4  Discussion 
SEMG has improved the detection rate of fasciculations compared to clinical examination or 
NEMG.(Howard and Murray, 1992, Hjorth et al., 1973) The advent of HDSEMG, where multiple 
channels are aligned in a linear or grid formation, has provided superior spatial resolution and muscle 
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coverage compared to single channel SEMG.(van Dijk et al., 2010) SPiQE combines this non-invasive 
sensor technology with an innovative signal-processing algorithm to quantify FPs in an accurate and 
automated way. Although other groups have applied automated techniques to FP analysis,(Drost et al., 
2007, Jahanmiri-Nezhad et al., 2014b) we aimed to combine relatively simple signal-processing 
methods to convert unrefined HDSEMG recordings into reliably interpretable results.  
 
The main challenge facing this automated analytical model concerned fluctuating noise levels.(De Luca 
et al., 2010) Biceps produced higher noise levels than gastrocnemius, prompting us to validate these 
muscles separately. The fact that the optimal models from each muscle were not significantly different 
from each other demonstrated the robustness of the analytical technique, which allowed us to pool the 
data to develop a unified model. 
 
An established method for calculating noise in EMG data is the root mean square.(Hug et al., 2006, 
Jahanmiri-Nezhad et al., 2014a) However, we did not feel this was the optimal approach in this setting. 
We defined the noise band to be directly comparable with the peak-trough amplitudes of potential 
fasciculations. A single noise band represented the average peak-trough noise within the immediate 
vicinity of its corresponding spike and could be calculated without significant computational expense.  
 
Importantly, the empirical relationship between noise band and optimal amplitude inclusion threshold 
was linear and the Y-intercept did not significantly differ from zero, leading to a simplification of the 
enhanced model. This latter observation seems intuitive when considering the hypothetical scenario of 
zero noise, in which case any amplitude deviation from zero would be a true signal. Not only was 
model 2 the most accurate, but it was also the most robust to shifts in background noise (figure 4a). 
Like others, our original approach had been to apply the same amplitude inclusion threshold across 
every recording.(de Carvalho and Swash, 2013, de Carvalho and Swash, 2016a) Anecdotally, we 
observed major problems with this approach, particularly in recordings with higher noise levels. By 
testing models 1 and 2 in parallel on the same representative recordings, we were able to confirm the 
superiority of a noise-responsive model.  
 
An interesting feature of the validation, as evidenced in figure 4, was that the sensitivity reached a 
saturation point with reducing A2 values. Our interpretation of this relied on understanding that false 
negatives in this context could be divided into two groups. In the first group were those events detected 
as spikes but whose amplitudes fell short of the amplitude inclusion threshold. The second group 
represented those that were not recognised as spikes in the first place, due to a probability threshold 
(set at 98%) that was not sufficiently inclusive. The observed saturation level in sensitivity was 
produced by the second group. This indicated a key avenue to explore to improve the model’s 
accuracy in future iterations. 
 
We estimated the accuracy of the two models using ROC analysis, adopted from its widely used role in 
clinical diagnostics.(Linden, 2006) To establish the ground truth, we developed a simple definition of a 
fasciculation potential for manual analysis, providing a standardised approach across all recordings. 
More than one assessor for manual counts would be beneficial,(Harding et al., 2016) however this is 
very time-consuming. The single assessor (JB) had accumulated the most experience in our group 
analysing raw HDSEMG data manually. 
 
Our analytical models have been trialed in a relatively small group of patients, however the inclusion of 
multiple visits, multiple muscles and control patients adds to the robustness of the optimal model. An 
internal cross-validation approach was used to provide less biased predictive parameters, however 
application in an external group of patients would enhance its validity.  
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We have focused on biceps and gastrocnemius as their size permits the use of large HDSEMG grids, 
thereby maximising data coverage for the purposes of validation and interpretation. Our decision to 
study gastrocnemius, a muscle known to produce prominent fasciculations in the healthy 
population,(Fermont et al., 2010, Simon and Kiernan, 2013) reinforces our aim to identify 
pathophysiological features that discriminate disease and healthy states. Moreover, these two muscles 
were the focus of a complementary automated analytical tool using ultrasound.(Harding et al., 2016) 
Ultrasound can provide diagnostic and practical advantages over EMG, suggesting the non-invasive 
combination of ultrasound and HDSEMG warrants exploration as we strive to understand the 
electromechanical properties of fasciculations.(Johansson et al., 2017, Tsuji et al., 2018)  
 
Fasciculations are a hallmark clinical feature in ALS and reflect early neuronal dysfunction so could 
provide a sensitive measure of motor neuron health. SPiQE was conceived as a means to understand 
the natural history of fasciculations in relation to disease progression, anticipating that this could be 
translated into a novel outcome measure in therapeutic trials. This validation is a promising 
introduction, paving the way for larger prospective studies. Although others have not found evidence 
that FP frequency correlates with neurological decline in ALS,(de Carvalho and Swash, 2016a) we felt 
that a more comprehensive approach based on an automated analytical method may be more fruitful. 
The aim would be to prospectively compare FP parameters, such as frequency or amplitude, with 
established markers of disease progression, including the ALS-Functional Rating Scale (ALS-FRS) and 
Motor Unit Number Index (MUNIX).(Cedarbaum et al., 1999, Neuwirth et al., 2015, Neuwirth et al., 
2017)  
 
5  Conclusion 
SPiQE is the first attempt at an automated tool to comprehensively identify fasciculations in ALS and 
related disorders using unrefined HDSEMG. Performing robustly amidst fluctuating noise levels, it 
achieves a favourable average classification accuracy of 88%.  Instead of relying on complex 
theoretical concepts, its design has been guided by real-world data collected prospectively from 
patients and controls. It is anticipated that this empirical approach will improve its translation into a 
meaningful clinical tool. Our multi-disciplinary group has combined expertise from bioengineering, 
clinical neurology and biostatistics - a combination that’s led to the customisation and simplification of 
the technical approach. Throughout our clinical study program, SPiQE will serve as a platform to 
discover potential correlations between pathological FP parameters and neurological decline in patients 
with ALS, thereby aiding the search for a novel disease biomarker.  
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Figure legends 
Figure 1. Data processing. a Probability threshold. The spike detection threshold was based on the 
probability of a given amplitude occurring in the thirty-minute recording. A spike’s duration was found 
by tracking the spike to its nearest zero point (orange circles). Adjacent phases (positive-negative 
transition) were joined and recorded as a single spike. b Principle of the super-channel (SC). For 
spikes A and B, the channel (1-4) with the highest peak-trough amplitude (shown in red) was 
transferred into the SC. The channel of origin for each spike was stored.   
 
Figure 2. Noise level analysis (phase one).  a Distribution of mean noise bands for biceps and 
gastrocnemius. Each data point represents one minute of recording. There was a significant difference in 
noise levels between biceps and gastrocnemius (p<0.0001, Mann-Whitney test). b. Relationships between 
mean noise band and optimal ATinc. ATinc was calculated from manual counts using 10s windows. The best-
fit lines were calculated with weighted least-squares regression due to heteroscedasticity of the data. For 
biceps (red), n was 295 and r2 was 0.648. For gastrocnemius (blue), n was 304 and r2 was 0.402. 
 
Figure 3. Receiver operating characteristic (ROC) curves for FP identification (phase three). a 
Comparison of two analytical models. For each muscle (biceps in red and gastrocnemius in blue), 40 
one-minute representative recordings were analysed. Model one (M1, triangle symbols) took the form 
Y=A1 and model two (M2, circular symbols) took the form Y=A2X, where Y was the optimal ATinc (μV), X 
was the mean noise band (μV) and A1/2 was a positive value. From left-to-right, threshold values for A1 
were 100, 60, 40, 35, 30, 25, 20, 15, 10 and 5, and values for A2 were 14, 12, 10, 9, 8, 7, 6, 5, 4 and 2. 
Median sensitivity and specificity are displayed (non-parametric distributions). Area-under-the curve 
(AUC, 2 s.f.) represents the accuracy of each model for each muscle. * indicates the performance of 
M1 when A1=40; ~ indicates performance of M1 when A1=20; # indicates the performance of M2 when 
A2=7. b Pooled results for model two. The results from biceps and gastrocnemius were pooled to 
produce a total of 80 one-minute recordings. Threshold values for A2 are displayed. Curves for median 
sensitivity and specificity are plotted alongside lower and upper limits for 95% confidence interval (CI). 
AUC represents the accuracy of this model. 
 
Figure 4. Data exclusion. a Finding the optimal amplitude exclusion threshold (ATexc). The ATexc was 
varied to calculate the sensitivity and specificity for 80 pooled (biceps and gastrocnemius) one-minute 
recordings. Boxes represent median and inter-quartile range (IQR). Whiskers represent (upper quartile 
+ 1.5*IQR) and (lower quartile -1.5*IQR) according to Tukey’s method. Data points beyond this range 
are plotted individually. b ATexc example - part 1. One minute of amplitude inclusion thresholds (linearly 
related to noise levels), showing a burst in noise levels between 1535-1540s. Amplitude exclusion 
threshold of 100μV (red line) applied to exclude shaded region. c ATexc example - part 2. 
Corresponding one minute of super-channel recording, showing exclusion of noisy period. 
Fasciculation count (369), time analysed (0.917m) and fasciculation frequency (403/m) have been 
automatically adjusted. 
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Figure 5. Application of the analytical pipeline. a FPs from raw data. Black bar indicates 5ms 
duration. b Example raw data. 60s of raw data from gastrocnemius of ALS patient 3. c Example SPiQE 
output. Super-channel of corresponding 60s of data in ‘b’ after application of optimal analytical pipeline. 
d Model performance. The optimal model (Y=8X) has been applied to 80 one-minute recordings and 
compared with high precision manual counts. Medians and 95% confidence intervals plotted. Wilcoxon 
signed-rank test confirms no significant difference (p=0.394). 
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Figure 1. Data processing. a Probability threshold. The spike detection threshold was based on 
the probability of a given amplitude occurring in the thirty-minute recording. A spike’s duration was 
found by tracking the spike to its nearest zero point (orange circles). Adjacent phases (positive-
negative transition) were joined and recorded as a single spike. b Principle of the super-channel 
(SC). For spikes A and B, the channel (1-4) with the highest peak-trough amplitude (shown in red) 
was transferred into the SC. The channel of origin for each spike was stored.    
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Figure 2. Noise level analysis (phase one).  a Distribution of mean noise bands for biceps and gastrocnemius. Each datapoint represents one minute of recording. There was a 
significant difference in noise levels between biceps and gastrocnemius (p<0.0001, Mann-Whitney test). b. Relationships between mean noise band and optimal ATinc. ATinc was 
calculated from manual counts using 10s windows. The best-fit lines were calculated with weighted least-squares regression due to heteroscedasticity of the data. For biceps (red), n 
was 295 and r2 was 0.648. For gastrocnemius (blue), n was 304 and r2 was 0.402.
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Figure 4. Receiver operating characteristic (ROC) curves for FP identification (phase three). a Comparison of two analytical models. For each muscle (biceps in red and 
gastrocnemius in blue), 40 one-minute representative recordings were analysed. Model one (M1, triangle symbols) took the form Y=A1 and model two (M2, circular symbols) took 
the form Y=A2X, where Y was the optimal ATinc (μV), X was the mean noise band (μV) and A1/2 was a positive value. From left-to-right, threshold values for A1 were 100, 60, 40, 35, 
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Figure 6. Application of the analytical pipeline. 
a FPs from raw data. Black bar indicates 5ms 
duration. b Example raw data. 60s of raw data 
from gastrocnemius of ALS patient 3. c Example 
SPiQE output. Super-channel of corresponding 
60s of data in ‘b’ after application of optimal 
analytical pipeline. d Model performance. The 
optimal model (Y=8X) has been applied to 80 
one-minute recordings and compared with high 
precision manual counts. Medians and 95% 
confidence intervals plotted. Wilcoxon signed-rank 
test confirms no significant difference (p=0.394). 
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